ArticleRSC advances2021
The roles of fused-ring organic semiconductor treatment on SnO
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Double Fence Porphyrins as Self-Assembled Monolayers for Tin-Based Perovskite Solar Cells.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It took only 11 years for the power conversion efficiency (PCE) of perovskite solar cells (PSCs) to increase from 3.8% to 25.2%. It is worth noting that, as a new thin-film solar cell technique, defect passivation at the interface is crucial for the PSCs. Decorating and passivating the interface between the perovskite and electron transport layer (ETL) is an effective way to suppress the recombination of carriers at the interface and improve the PCE of the device. In this work, several acceptor-donor-acceptor (A-D-A) type fused-ring organic semiconductors (FROS) with indacenodithiophene (IDT) or indacenodithienothiophene (IDDT) as the bridging donor moiety and 1,3-diethyl-2-thiobarbituric or 1,1-dicyromethylene-3-indanone as the strong electron-withdrawing units, were deposited on the SnO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.